William D. Schmitz - Concepedia

Author

William D. Schmitz

Bristol-Myers Squibb (United States)ORCID

Also Known As

O. Schober, Schmitz,William, W SCHMITZ, W. D. SCHMITZ, W. D. Schmitz, W. Schmitz, William D. Schmitz, William Schmitz, William D. Schmitz

Publications

455

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Colorado State University

About

William D. Schmitz is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	118
2	Natural Sciences	3	3	72
3	Biochemistry	3	3	72
4	Engineering	1	1	29
5	Social Sciences	1	1	26

William D. Schmitz

Publications

360

Citations

H-Index

Page 1

	Year	Citations
The Synthesis of Streptogramin Antibiotics: (−)‐Griseoviridin and Its C‐8 Epimer Curt A. Dvorak, William D. Schmitz, Daniel J. Poon, Angewandte Chemie International Edition	2000	134
The Synthesis of Streptogramin Antibiotics: (−)-Griseoviridin and Its C-8 Epimer Curt A. Dvorak, William D. Schmitz, Daniel J. Poon, Angewandte Chemie Bioorganic ChemistryAntimicrobial ChemotherapyHeterocycle ChemistryPharmaceutical ChemistryMedicinal Chemistry	2000	39
In Vitro Intrinsic Clearance-Based Optimization of<i>N</i><sup>3</sup>-Phenylpyrazinones as Corticotropin-Releasing Factor-1 (CRF<sub>1</sub>) Receptor Antagonists Richard A. Hartz, Vijay T. Ahuja, Maria Rafalski, Journal of Medicinal Chemistry	2009	37
Synthesis, Structure−Activity Relationships, and In Vivo Evaluation of<i>N</i><sup>3</sup>-Phenylpyrazinones as Novel Corticotropin-Releasing Factor-1 (CRF<sub>1</sub>) Receptor Antagonists Richard A. Hartz, Vijay T. Ahuja, Argyrios G. Arvanitis, Journal of Medicinal Chemistry	2009	32
A new route to 2-substituted Δ2-thiazolines: Stille cross-couplings of 2-bromo-Δ2-thiazolines William D. Schmitz, Daniel Romo Tetrahedron Letters EngineeringOrganic ChemistryChemistryHeterocycle ChemistryBiomolecular Engineering	1996	29
Homotryptamines as potent and selective serotonin reuptake inhibitors (SSRIs) William D. Schmitz, Derek J. Denhart, Allison B. Brenner, Bioorganic & Medicinal Chemistry Letters Psychoactive DrugPsychiatryMedicinePsychopharmacologyDepression	2005	26
Synthesis and structure–activity relationships of N3-pyridylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists Richard A. Hartz, Vijay T. Ahuja, William D. Schmitz, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyBiochemistryMedicineCorticotropin-releasing Factor-1Natural Sciences	2010	23
Quantitation of Clobazam in Human Plasma Using High-Performance Liquid Chromatography Jörg Knapp, H. Gumbinger, Bettina Linck, Journal of Chromatographic Science Other Antiepileptic CompoundsTherapeutic Drug MonitoringMedicinal ChemistryAnalytical Hplc SystemDrug Purity	1999	20
An Efficient, Direct Bis-ortho-chlorination of 4-(Difluoromethoxy)aniline and Its Application to the Synthesis of BMS-665053, a Potent and Selective Pyrazinone-Containing Corticotropin-Releasing Factor-1 Receptor Antagonist Jianqing Li, Daniel Smith, Subramaniam Krishnananthan, Organic Process Research & Development Medicinal ChemistryChemical EngineeringDirect Bis-ortho-chlorinationCross-coupling ReactionBiochemistry	2011	10
Development of BET Inhibitors as Potential Treatments for Cancer: Optimization of Pharmacokinetic Properties Matthew D. Hill, Haiquan Fang, Derek Norris, ACS Medicinal Chemistry Letters	2022	10

Page 1